Clinical Research Directory
Browse clinical research sites, groups, and studies.
Compare Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause
Sponsor: Mackay Memorial Hospital
Summary
The definition of Genitourinary Syndrome of Menopause (GSM) is the decline of estrogens during menopause results in symptoms and clinical signs from both systems. Estrogen and other hormones production decrease after menopause because the ovaries lose their effectiveness, leading to mucosal atrophy, reduced vaginal moisture, dysuria, urgency, recurrent infection, burning, pruritus and dyspareunia. The treatment included vaginal estrogen supplement, vaginal hyaluronic acid supplement, vaginal laser, platelet rich plasma, etc. Observational cohort study will be used for study design, and questionnaire, pelvic examination, vaginal pap smear with maturation index (MI), vaginal pH, and other methods will be used for evaluation of the effectiveness and side effects.
Official title: Compare the Effectiveness and Side Effects of Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause
Key Details
Gender
FEMALE
Age Range
45 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
40
Start Date
2025-12-01
Completion Date
2027-06-30
Last Updated
2025-05-09
Healthy Volunteers
No
Interventions
Vaginal estrogen supplement
Daily vaginal estrogen supplement, then twice per week. Continue for three months.
Platelet-rich plasma injection
Monthly platelet-rich plasma injection for three months
Locations (1)
MacKay Memorial Hospital
Taipei, Taiwan